BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Biotech Bay

  Soleno Therapeutics to Participate in the BIO CEO & Investor Conference

  Soleno Therapeutics, Inc. announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present a corporate overview at the BIO CEO & Investor Conference on Tuesday, February 15, 2022 at 2:15 PM Eastern Time.

  February 8, 2022

   · 

  1 min read
• BioForest

  Seagen to Present at the 11th Annual SVB Leerink Global Healthcare Conference

  Seagen Inc. announced that management will participate in a virtual fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 2:20 p.m. Eastern Time.

  February 8, 2022

   · 

  1 min read
• Congruence Therapeutics Inc. Announces US$50 million Series A Financing to Advance Platform Targeting Diseases of Protein Misfolding

  Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding, announced the closing of a US$50 million, tranched, series A financing.

  February 8, 2022

   · 

  4 min read
• Genetown

  Aphios Granted US Patent For Combination HIV Latency Nanoparticles Towards an HIV Cure

  Aphios Corporation announced today that it has been granted US Patent No. 11,234,932 for treating HIV latency towards an HIV cure.

  February 8, 2022

   · 

  2 min read
• FDA

  Eureka Therapeutics Receives Orphan Drug Designations for Treatment of Hepatocellular Carcinoma (HCC) With ARTEMIS® T Cells

  Eureka Therapeutics Receives Orphan Drug Designations for Treatment of Hepatocellular Carcinoma (HCC) With ARTEMIS ® T Cells.

  February 8, 2022

   · 

  3 min read
• Drug Development

  Intrommune Reports Positive Update from Ongoing Phase 1 Study in Peanut Allergy

  Intrommune Therapeutics, Inc. today announced an initial update from its ongoing Phase 1 OMEGA Trial of INT301 in patients with peanut allergy.

  February 8, 2022

   · 

  4 min read
• Business

  Neuvivo Adds James Kovach, MD, former NFL Player, and Current Executive Director of UC Davis Health Translational Entrepreneurship Program to Advisory Board

  Neuvivo today announced the expansion of its Advisory Board, adding James Kovach, MD, JD as a new member.

  February 8, 2022

   · 

  2 min read
• Pharm Country

  Schrödinger to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference

  Schrödinger announced that management will provide a company overview at the SVB Leerink Virtual 11th Annual Global Healthcare Conference.

  February 8, 2022

   · 

  1 min read
• Business

  AMGEN PROVIDES LONG-TERM GUIDANCE THROUGH 2030 DURING BUSINESS REVIEW MEETING

  In connection with its virtual business review, Amgen (NASDAQ:AMGN) provided preliminary long-term guidance between 2022 and 2030 in addition to full year 2022 guidance.

  February 8, 2022

   · 

  10 min read
• Biotech Beach

  Evolus Receives Acceptance of Submission in Australia, a Pivotal Step in Approval Process for Nuceiva®

  Evolus Receives Acceptance of Submission in Australia, a Pivotal Step in Approval Process for Nuceiva ® .

  February 8, 2022

   · 

  4 min read